Consider Praxbind to Reverse Pradaxa In Patients with Life-Threatening Bleeding

December 2015

Praxbind (PRAKS-bynd, idarucizumab) will be the first reversal agent for ONE of the direct oral anticoagulants.

Praxbind is an IV monoclonal antibody fragment that binds to the thrombin inhibitor, Pradaxa (dabigatran), to reverse anticoagulation.

But Praxbind won't work for factor Xa inhibitors...Xarelto (rivaroxaban), Eliquis (apixaban), or Savaysa (edoxaban).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote